Pinz Capital Management, LP Mersana Therapeutics, Inc. Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.84 - $5.0 $1.14 Million - $2 Million
-400,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.74 - $6.63 $1.5 Million - $2.65 Million
400,000 New
400,000 $1.6 Million
Q3 2020

Nov 16, 2020
SELL
$16.2 - $25.7 $980,100 - $1.55 Million
-60,500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$5.24 - $23.4 $317,020 - $1.42 Million
60,500 New
60,500 $1.42 Million

Others Institutions Holding MRSN

# of Institutions
127
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $66.1M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email